GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of MAPK cascade | ||
positive regulation of cell adhesion | ||
negative regulation of lipid storage | ||
positive regulation of MAP kinase activity | ||
cellular response to type II interferon |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular region | ||
external side of plasma membrane | ||
neuronal cell body | ||
cell surface | ||
plasma membrane |
GO Term | Evidence Code | PMID |
---|---|---|
death receptor agonist activity | ||
cytokine activity | ||
tumor necrosis factor receptor binding | ||
protein binding | ||
transcription cis-regulatory region binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:0050866 | oral squamous cell carcinoma | |
DOID:0050881 | inclusion body myopathy with Paget disease of bone and frontotemporal dementia | |
DOID:0050908 | myelodysplastic syndrome | |
DOID:0060224 | atrial fibrillation | |
DOID:0060319 | cardiac arrest | |
DOID:0060643 | primary sclerosing cholangitis | |
DOID:0080162 | lupus nephritis | |
DOID:0080208 | metabolic dysfunction-associated steatotic liver disease | |
DOID:0080547 | metabolic dysfunction-associated steatohepatitis | |
DOID:0080600 | COVID-19 |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
100009088 | RABIT02187 | ||
100764780 | CRIGR18076 | ||
21926 | MGI:104798 | MOUSE20698 | |
24835 | RGD:3876 | RATNO21568 | |
100135630 | CAVPO08877 | ||
101581069 | OCTDE02199 | ||
100023069 | MONDO10816 | ||
102449532 | PELSI00816 | ||
100561101 | ANOCA03845 | ||
103682322 | URSMA31952 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024